Nucleic Acid Biochemistry — MCQs
On this page
Which of the following statements is true regarding the sigma factor?
C4, C5, and N7 in the purine ring are derived from which of the following?
What is the end product of purine metabolism in most mammals?
The gaps between Okazaki fragments on the lagging strand during DNA replication are rejoined and sealed by:
What is the first purine nucleotide synthesized in de novo purine biosynthesis?
What are Okazaki fragments?
Rate limiting step in pyrimidine synthesis?
In eukaryotic cells, where does the majority of functional RNA activity occur?
Which type of RNA is primarily involved in gene silencing?
Which of the following organs does not primarily utilize the salvage pathway of purine nucleotide synthesis?
Nucleic Acid Biochemistry Indian Medical PG Practice Questions and MCQs
Question 201: Which of the following statements is true regarding the sigma factor?
- A. It is a subunit of DNA polymerase.
- B. It is a subunit of RNA polymerase. (Correct Answer)
- C. It initiates DNA replication.
- D. It is a subunit of the 50s ribosome.
Explanation: ***It is a subunit of RNA polymerase.*** - The **sigma factor** is a crucial component of **bacterial RNA polymerase**, guiding it to specific promoter regions on the DNA. - It plays a vital role in **initiation of transcription** by recognizing and binding to the **-10 and -35 boxes** of the promoter. *It is a subunit of DNA polymerase.* - **DNA polymerase** is primarily involved in **DNA replication and repair**, not transcription. - Its subunits, such as the **beta clamp** or **alpha subunit**, are distinct from the sigma factor. *It initiates DNA replication.* - **DNA replication** is initiated by **DNA helicases** unwinding the double helix and **primase** synthesizing RNA primers. - The sigma factor's role is in **transcription**, the synthesis of RNA from a DNA template. *It is a subunit of the 50s ribosome.* - The **50S ribosomal subunit** is a component of the **ribosome**, responsible for **peptide bond formation** during translation. - Its subunits are ribosomal proteins and ribosomal RNA molecules, not the sigma factor.
Question 202: C4, C5, and N7 in the purine ring are derived from which of the following?
- A. CO₂
- B. Aspartate
- C. Glutamine
- D. Glycine (Correct Answer)
Explanation: ***Glycine*** - The entire **glycine molecule** contributes C4, C5, and N7 to the purine ring structure. - This amino acid provides a significant portion of the backbone to the imidazole ring within the purine. *Aspartate* - **Aspartate** contributes N1 to the purine ring. - It does not involve C4, C5, or N7, which are distinct atoms within the purine molecule. *CO₂* - **CO₂** contributes C6 to the purine ring through a carboxylation step. - It is not involved in providing the atoms at positions C4, C5, or N7. *Glutamine* - The nitrogen atoms N3 and N9 in the purine ring are derived from the **amide nitrogen of glutamine**. - Glutamine's contributions are different from the carbons and nitrogen provided by glycine.
Question 203: What is the end product of purine metabolism in most mammals?
- A. Glycogen
- B. Pyrimidine
- C. Histidine
- D. Allantoin (Correct Answer)
Explanation: ***Allantoin*** - **Allantoin** is the primary end product of **purine metabolism** in **most mammals** (except humans and higher primates), formed by the oxidation of uric acid by the enzyme **uricase**. - This conversion makes purine waste products more **water-soluble** and easier to excrete via the kidneys. - **Important clinical note:** Humans lack functional uricase, so **uric acid** is the end product in humans; this distinction is why hyperuricemia and gout occur in humans but not in most other mammals. *Glycogen* - **Glycogen** is a complex carbohydrate and serves as a primary **energy storage molecule** in animals, derived from glucose metabolism, not purine catabolism. - Its metabolism is regulated by hormones like **insulin** and **glucagon**, involved in maintaining blood glucose levels. *Pyrimidine* - **Pyrimidine** is a type of nitrogenous base, structurally distinct from purines, and is a component of DNA and RNA, not an end product of purine catabolism. - **Pyrimidine metabolism** involves the synthesis and breakdown of bases like cytosine, thymine, and uracil, which follows a separate biochemical pathway. *Histidine* - **Histidine** is an **essential amino acid**, a building block of proteins, and is involved in various metabolic processes, including histamine synthesis. - It plays no role as an end product of purine degradation; rather, its own metabolism leads to products like **urocanic acid**.
Question 204: The gaps between Okazaki fragments on the lagging strand during DNA replication are rejoined and sealed by:
- A. DNA Ligase (Correct Answer)
- B. DNA Helicase
- C. DNA Phosphorylase
- D. DNA Topoisomerase
Explanation: ***DNA Ligase*** - **DNA ligase** forms a **phosphodiester bond** between the **3'-OH group** of one Okazaki fragment and the **5'-phosphate group** of the adjacent fragment, effectively sealing the nicks. - After **DNA polymerase I** removes the **RNA primers** and fills in the gaps, DNA ligase completes the synthesis of the **lagging strand** during DNA replication. - This enzyme is essential for maintaining the **integrity of the DNA backbone**. *DNA Helicase* - **DNA helicase** functions to **unwind the DNA double helix**, separating the two strands to create a replication fork. - It does not participate in joining DNA fragments. *DNA Phosphorylase* - **DNA phosphorylase** is not a standard enzyme involved in the direct sealing of DNA fragments during replication. - This is not the enzyme responsible for ligating Okazaki fragments. *DNA Topoisomerase* - **DNA topoisomerase** relieves the **supercoiling tension** that builds up in the DNA double helix ahead of the replication fork due to unwinding. - It does not have a role in forming phosphodiester bonds between newly synthesized DNA fragments.
Question 205: What is the first purine nucleotide synthesized in de novo purine biosynthesis?
- A. AMP
- B. GMP
- C. IMP (Correct Answer)
- D. UMP
Explanation: ***IMP (Inosine Monophosphate)*** - **IMP** is the first complete purine nucleotide synthesized during the **de novo purine biosynthesis pathway**. - It serves as a branch point, from which **AMP** and **GMP** are subsequently synthesized through separate pathways. *AMP (Adenosine Monophosphate)* - **AMP** is a derivative of **IMP**, synthesized by the addition of an amino group from **aspartate** to IMP. - This step occurs after the formation of the complete purine ring structure in IMP. *GMP (Guanosine Monophosphate)* - **GMP** is also derived from **IMP**, through a pathway involving the oxidation of IMP to **XMP** (xanthosine monophosphate) and subsequent amination. - Its synthesis occurs downstream from IMP. *UMP (Uridine Monophosphate)* - **UMP** is a **pyrimidine nucleotide**, not a purine, and is synthesized via a completely different de novo pathway. - Pyrimidine biosynthesis involves forming the ring structure first, then attaching it to ribose-phosphate, unlike purine synthesis which builds the ring on a pre-existing ribose-phosphate.
Question 206: What are Okazaki fragments?
- A. Long pieces of DNA on the lagging strand.
- B. Short pieces of DNA on the lagging strand. (Correct Answer)
- C. Short pieces of DNA on the leading strand.
- D. Long pieces of DNA on the leading strand.
Explanation: ***Short pieces of DNA on the lagging strand.*** - **Okazaki fragments** are the short, newly synthesized DNA fragments that are formed on the **lagging strand** during DNA replication. - The lagging strand is synthesized discontinuously because DNA polymerase can only add nucleotides in the **5' to 3' direction**, requiring it to move away from the replication fork as the DNA unwinds. *Long pieces of DNA on the lagging strand.* - The lagging strand is synthesized discontinuously in **short fragments**, not long continuous pieces. - The enzyme **DNA ligase** eventually joins these short fragments together to form a continuous strand. *Short pieces of DNA on the leading strand.* - The **leading strand** is synthesized continuously in one long stretch, moving towards the replication fork. - It does not require the synthesis of short fragments like the lagging strand. *Long pieces of DNA on the leading strand.* - While the leading strand is synthesized in a continuous, long piece, this statement does not accurately describe Okazaki fragments, which are specific to the lagging strand. - The leading strand's continuous synthesis is due to its **3' to 5' template orientation**, allowing DNA polymerase to proceed uninterrupted.
Question 207: Rate limiting step in pyrimidine synthesis?
- A. Aspartate transcarbamoylase (ATCase)
- B. Dihydroorotate dehydrogenase
- C. Dihydro-orotase
- D. Carbamoyl phosphate synthase-II (Correct Answer)
Explanation: ***Carbamoyl phosphate synthetase II (CPS-II)*** - **CPS-II** is the **committed and rate-limiting enzyme** in **de novo pyrimidine synthesis** in **mammals (including humans)** - It catalyzes the formation of **carbamoyl phosphate** from glutamine, CO₂, and 2 ATP in the **cytoplasm** - This is the **first committed step** and the main **regulatory checkpoint**, inhibited by UTP (feedback inhibition) and activated by PRPP and ATP - CPS-II is part of the **CAD complex** (carbamoyl phosphate synthetase, aspartate transcarbamoylase, dihydroorotase) in mammals *Aspartate transcarbamoylase (ATCase)* - ATCase catalyzes the **second step**: condensation of carbamoyl phosphate with aspartate to form carbamoyl aspartate - While ATCase is the **rate-limiting step in bacteria** (E. coli), in **mammals** it is part of the CAD complex and **not the primary regulatory step** - This option is incorrect for human/mammalian biochemistry tested in NEET PG *Dihydro-orotase* - The **third enzyme** in the pathway, converting carbamoyl aspartate to dihydroorotate - Part of the CAD complex in mammals but **not the rate-limiting step** *Dihydroorotate dehydrogenase* - Catalyzes the **fourth step**: oxidation of dihydroorotate to orotate - Located on the **outer surface of the inner mitochondrial membrane** (only mitochondrial enzyme in the pathway) - Important enzyme but **not rate-limiting**
Question 208: In eukaryotic cells, where does the majority of functional RNA activity occur?
- A. Nucleus
- B. Ribosome
- C. Cytoplasm (Correct Answer)
- D. None of the options
Explanation: ***Cytoplasm*** - The **cytoplasm** is the cellular compartment where the **majority of functional RNA activity** occurs, including **translation** (protein synthesis) involving mRNA, tRNA, and rRNA. - **Ribosomes** (the sites of translation) are located in the cytoplasm, either free-floating or bound to the endoplasmic reticulum. - Many types of **regulatory RNAs** such as microRNAs (miRNAs) and small interfering RNAs (siRNAs) exert their functions in the cytoplasm by targeting mRNAs for degradation or translational repression. - **mRNA degradation** and **RNA interference pathways** primarily operate in the cytoplasm. - The question asks for the broader location rather than the specific molecular machinery, making cytoplasm the most comprehensive answer. *Nucleus* - While RNA is **transcribed** from DNA and **processed** (capping, polyadenylation, splicing) in the nucleus, these are preparatory steps. - The nucleus is primarily the site of **RNA synthesis**, not where most RNA performs its functional roles. - Only a small fraction of functional RNA activity (like rRNA processing in the nucleolus) occurs here compared to the cytoplasm. *Ribosome* - While **ribosomes are the specific sites of translation** and are composed of rRNA and proteins, they represent molecular machinery rather than a cellular location. - Ribosomes themselves are located **within the cytoplasm**, making cytoplasm the more inclusive answer for where RNA activity occurs. - The question asks "where" in terms of cellular compartment, not which molecular complex. *None of the options* - This is incorrect as the cytoplasm is indeed the primary site where the majority of functional RNA activities occur in eukaryotic cells.
Question 209: Which type of RNA is primarily involved in gene silencing?
- A. rRNA
- B. tRNA
- C. miRNA (Correct Answer)
- D. mRNA
Explanation: ***miRNA*** - **miRNA** (microRNA) is a small non-coding RNA molecule that plays a crucial role in **post-transcriptional regulation of gene expression**. - It functions by binding to complementary messenger RNA (mRNA) molecules, leading to **mRNA degradation** or **inhibition of translation**, thereby silencing genes. - miRNA is the primary RNA type involved in **gene silencing** through the RNA interference (RNAi) pathway. *rRNA* - **rRNA** (ribosomal RNA) is a primary component of **ribosomes**, the cellular machinery responsible for protein synthesis. - Its main function is to **catalyze peptide bond formation** and provide structural integrity to the ribosome, not gene silencing. *tRNA* - **tRNA** (transfer RNA) is responsible for carrying specific **amino acids** to the ribosome during protein synthesis. - It acts as an adapter molecule, translating the **genetic code** in mRNA into an amino acid sequence. *mRNA* - **mRNA** (messenger RNA) carries genetic information from **DNA to ribosomes** for protein synthesis. - While mRNA can be targeted by gene silencing mechanisms (like miRNA), it is not the RNA type that performs the silencing function itself.
Question 210: Which of the following organs does not primarily utilize the salvage pathway of purine nucleotide synthesis?
- A. RBC
- B. Leukocytes
- C. Liver (Correct Answer)
- D. Brain
Explanation: ***Liver*** - The **liver** is capable of both *de novo* synthesis and the salvage pathway of purine nucleotides, but it primarily utilizes the **de novo pathway** due to its high metabolic capacity and central role in biosynthesis for the entire body. - While salvage pathways exist, the liver's robust *de novo* synthesis allows it to readily produce purines from simple precursors, making it less reliant on salvaging pre-formed bases. *Brain* - The **brain** relies heavily on the **salvage pathway** for purine nucleotide synthesis because it has a limited capacity for *de novo* purine synthesis. - This dependency makes the brain particularly vulnerable to deficiencies in salvage enzymes, such as in **Lesch-Nyhan syndrome** where HGPRT deficiency leads to severe neurological dysfunction. *RBC* - **Red blood cells (RBCs)** are anucleated and lack the machinery for *de novo* purine synthesis, making them entirely dependent on the **salvage pathway** to maintain their purine nucleotide pool. - They salvage pre-formed purine bases and nucleosides from the plasma to synthesize necessary adenine and guanine nucleotides. *Leukocytes* - **Leukocytes**, particularly lymphocytes, have a high turn-over rate and metabolic activity, and they primarily rely on the **salvage pathway** for purine nucleotide synthesis. - The **immune system's rapid proliferation** and response demand efficient nucleotide synthesis, and the salvage pathway offers a quick and energy-efficient way to achieve this.
Practice by Chapter
Nucleotide Structure and Function
Practice Questions
DNA Structure and Replication
Practice Questions
RNA Structure and Types
Practice Questions
Transcription: RNA Synthesis
Practice Questions
Post-Transcriptional Modifications
Practice Questions
Translation: Protein Synthesis
Practice Questions
Genetic Code and Codon Usage
Practice Questions
Regulation of Gene Expression
Practice Questions
Mutations and DNA Repair
Practice Questions
Purine Metabolism and Disorders
Practice Questions
Pyrimidine Metabolism and Disorders
Practice Questions
Nucleotide Degradation and Salvage Pathways
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free